Rabbit Polyclonal PYGL antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 5 publications. Immunogen corresponding to Recombinant Fragment Protein within Human Glycogen phosphorylase, liver form aa 700 to C-terminus.
View Alternative Names
PYGL
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-PYGL antibody (AB223788)
PFA-fixed, Triton X-100 permeabilized U-251 MG (human brain glioma cell line) cells stained for PYGL (green) using ab223788 at 4 μg/ml in ICC/IF.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PYGL antibody (AB223788)
Paraffin-embedded human liver tissue stained for PYGL using ab223788 at 1/500 dilution in immunohistochemical analysis.
- WB
Supplier Data
Western blot - Anti-PYGL antibody (AB223788)
All lanes:
Western blot - Anti-PYGL antibody (ab223788) at 1/250 dilution
All lanes:
U-251 MG (human brain glioma cell line) cell lysate
Predicted band size: 97 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme plays a major role in maintaining energy homeostasis by mobilizing glucose from glycogen stores during fasting states. It does not function as part of a larger complex operating instead as a homodimer when activated. PYGL is critical for the liver's ability to supply glucose to other organs when dietary glucose is not available. Proper functioning of PYGL helps maintain a balance between glucose storage and release contributing to overall metabolic equilibrium.
Pathways
PYGL has a notable role in glycogenolysis a process that liberates stored glycogen as glucose-1-phosphate. This enzyme also connects with gluconeogenesis where it impacts the production of glucose from non-carbohydrate sources. In these pathways its activity often intersects with other enzymes namely phosphoglucomutase and glucose-6-phosphatase which further process the products of PYGL’s activity.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Journal for immunotherapy of cancer 13: PubMed40954077
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:13670 PubMed38871968
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 133: PubMed38099490
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:112578 PubMed37267108
2023
Applications
Unspecified application
Species
Unspecified reactive species
Carbohydrate polymers 243:116435 PubMed32532388
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com